ÁLVARO
PRADA IÑURRATEGUI
Publicaciones (28) Publicaciones de ÁLVARO PRADA IÑURRATEGUI
2023
-
Dysautonomia and small fiber neuropathy in post-COVID condition and Chronic Fatigue Syndrome
Journal of Translational Medicine, Vol. 21, Núm. 1
-
Early biochemical analysis of COVID-19 patients helps severity prediction
PLoS ONE, Vol. 18, Núm. 5 May
-
Immune cell population and cytokine profiling suggest age dependent differences in the response to SARS-CoV-2 infection
Frontiers in Aging, Vol. 4
-
In-depth blood immune profiling of Good syndrome patients
Frontiers in Immunology, Vol. 14
-
Laboratory and clinical practices in antinuclear antibody detection and related antigens: recommendations from a Spanish multicentre survey
Immunologic Research, Vol. 71, Núm. 5, pp. 749-759
-
Recommendations for the use of anti-dsDNA autoantibodies in the diagnosis and follow-up of systemic lupus erythematosus – A proposal from an expert panel
Autoimmunity Reviews, Vol. 22, Núm. 12
2022
-
Brain fog of post-COVID-19 condition and Chronic Fatigue Syndrome, same medical disorder?
Journal of Translational Medicine, Vol. 20, Núm. 1
2021
-
Autoimmune GFAP astrocytopathy presenting with remarkable CNS hyperexcitability and oculogyric crises
Journal of Neuroimmunology, Vol. 359
-
O group is a protective factor for COVID19 in Basque population
PLoS ONE, Vol. 16, Núm. 4 April
-
The age again in the eye of the COVID-19 storm: evidence-based decision making
Immunity and Ageing, Vol. 18, Núm. 1
2020
-
COVID-19: Age, Interleukin-6, C-reactive protein, and lymphocytes as key clues from a multicentre retrospective study
Immunity and Ageing, Vol. 17, Núm. 1
-
Whole-transcriptome analysis in peripheral blood mononuclear cells from patients with lipid-specific oligoclonal igm band characterization reveals two circular RNAs and two linear rnas as biomarkers of highly active disease
Biomedicines, Vol. 8, Núm. 12, pp. 1-16
2019
-
ABO blood group distributions in multiple sclerosis patients from Basque Country; O- as a protective factor
Multiple Sclerosis Journal - Experimental, Translational and Clinical, Vol. 5, Núm. 4
-
Multi-centre validation of a flow cytometry method to identify optimal responders to interferon-beta in multiple sclerosis
Clinica Chimica Acta, Vol. 488, pp. 135-142
2018
-
The first dose of fingolimod affects circulating extracellular vesicles in multiple sclerosis patients
International Journal of Molecular Sciences, Vol. 19, Núm. 8
2015
-
Assessment of the reproducibility of oligoclonal IgM band detection for its application in daily clinical practice
Clinica Chimica Acta, Vol. 438, pp. 67-69
-
Identification of ncRNAs as potential therapeutic targets in multiple sclerosis through differential ncRNA - mRNA network analysis
BMC Genomics, Vol. 16, Núm. 1
-
Lipid-specific immunoglobulin M bands in cerebrospinal fluid are associated with a reduced risk of developing progressive multifocal leukoencephalopathy during treatment with natalizumab
Annals of Neurology, Vol. 77, Núm. 3, pp. 447-457
2014
-
Circulating microparticles reflect treatment effects and clinical status in multiple sclerosis
Biomarkers in Medicine, Vol. 8, Núm. 5, pp. 653-661